Northpond Ventures, LLC
- SEC CIK
- 0001911245
- Latest filing
- Nov 14, 2024
Holdings in Q4 2022
Holdings as of Dec 31, 2022, filed Feb 1, 2023. Long positions only; changes compare share counts with Q3 2022.
- Positions
- 5
- 0 vs. Q3 2022
- Portfolio value
- $184.3M
- +$41.6M (+29.2%) vs. Q3 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| DICEDICE Therapeutics, Inc. | COM | 3,292,871 | $102.7M | 55.7% | 00.0% | Unchanged | History |
| VIGLVigil Neuroscience, Inc. | COM | 4,214,498 | $52.7M | 28.6% | 00.0% | Unchanged | History |
| ISOIsoPlexis Corp | COM | 8,808,531 | $13.7M | 7.4% | 00.0% | Unchanged | History |
| TBIOTelesis Bio Inc. | COM | 9,844,130 | $11.8M | 6.4% | 00.0% | Unchanged | History |
| CADLCandel Therapeutics, Inc. | COM | 1,935,215 | $3.46M | 1.9% | 00.0% | Unchanged | History |